Potential health benefits of continuous LNG-IUS combined with parenteral ERT for seamless menopausal transition and beyond – a commentary based on clinical experience

References

• Grodstein F, Manson JE, Stampfler MJ. Postmenopausal hormone use and secondary prevention of coronary events in the Nurses Health Study. Ann Intern Med 2001;135:1–8
   PubMed Web of Science ®Google Scholar
• Hodis HN, Mack WJ, Lobo RA, et al.; Estrogen in the Prevention of Atherosclerosis Trial Research Group. Estrogen in the prevention of atherosclerosis: a randomized, double blind, placebo-controlled trial. Ann Intern Med 2001;135:993–53
   Google Scholar
• Sator P-G, Schmidt JB, Sator MO, et al. The influence of hormone replacement therapy on skin ageing: a pilot study. Maturitas 2001;39:43–55
   PubMed Web of Science ®Google Scholar
• Westendorp IC, in't Veld BA, Grobbee DE, et al. Hormone replacement therapy and peripheral arterial disease: the Rotterdam study. Arch Intern Med 2000;160:2498–502
   PubMed Web of Science ®Google Scholar
• Sherwin BB. Estrogen and cognitive functioning in women. Endocr Rev 2003;24:133–51
   PubMed Web of Science ®Google Scholar
• Tang MX, Jacobs D, Stern Y, et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996;348:429–32
   PubMed Web of Science ®Google Scholar
• Zandi PP, Carlson MC, Plassman BL, et al. Cache County Memory Study Investigators. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA 2002;288:2123–9
   PubMed Web of Science ®Google Scholar
• Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of oestrogen plus progestagen in healthy postmenopausal women. JAMA 2002;288:321–33
   PubMed Web of Science ®Google Scholar
• Million Women Study Collaborator. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003;362:419–27
   PubMed Web of Science ®Google Scholar
• Hully SB, Grady D. The WHI oestrogen-alone trial – do things look any better. JAMA 2004;291:1769–71
   PubMed Web of Science ®Google Scholar
• Olsson HL, Ingvar C, Bladstrom A. Hormone replacement therapy progestins and given continuously increases breast carcinoma risk in Sweden. Cancer 2003;97:1387–92
   PubMed Web of Science ®Google Scholar
• Sarrel PM. How progestins compromise the cardioprotective effects of estrogens (Editorial). Menopause 1995;2:187–90
   Web of Science ®Google Scholar
• Anderson GL, Chlebowski RT, Aragaki AK, et al. Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women’s Health Initiative randomized placebo-controlled trial. Lancet Oncol 2012;13:467–86
   Google Scholar
• Schierbeck LL, Rejnmark L, Landbo Tofteng C, et al. Effect of hormone replacement on cardiovascular events in recently postmenopausal women: a randomized trial. BMJ 2012;345:e6409. doi: 10.1136/bmj.e6409
   PubMed Web of Science ®Google Scholar
• Scarabin PY, Oger E, Plu-Bureau G. Differential association of oral and transdermal estrogen-replacement with venous thromboembolism risk. Lancet 2003;362:428–32
   PubMed Web of Science ®Google Scholar
• Andersson K, Mattsson LA, Rybo G, Stadberg E. Intrauterine release of levonorgestrel – a new way of adding progestogen in hormone replacement therapy. Obstet Gynecol 1992;79:963–7
   PubMed Web of Science ®Google Scholar
• Wildemeersch D, Janssens D, Weyers S. Continuous combined parenteral estrogen substitution and intrauterine progestogen delivery: the ideal HST combination? Maturitas 2005;51:207–14
   PubMed Web of Science ®Google Scholar
• Backman T, Rauramo I, Jaakkola K, et al. Use of the levonorgestrel-releasing intrauterine system and breast cancer. Obstet Gynecol 2005;106:813–17
   PubMed Web of Science ®Google Scholar
• Depypere HT, Hillard T, Erkkola R, et al. A 60-month non-comparative study on bleeding profiles with the levonorgestrel intrauterine system from late transition period to estrogen supplemented menopause. Eur J Obstet Gynecol Repod Biol 2010;153:176–80
   PubMed Web of Science ®Google Scholar
• Brzechffa PR, Judd HL. Hot flashes. In: Fraser IS, Jansen RPS, Lobo RA, Whitehead MI, eds. Estrogens and progestogens in clinical practice. London: Churchill Livingstone; 1998:635–45
   Google Scholar
• Manson JE (moderator). Presidential Symposium: Plenary symposium #1: New findings from the Kronos Early Estrogen Prevention Study (KEEPS) randomized trial. Program and abstracts of the North American Menopause Society 23rd Abnnual Meeting; October 3–6, 2012; Orlando, FL
   Google Scholar
• Bachman GA. The change before the ‘change’: strategy for transition to the menopause. Postgrad Med 1994;95:113–24
   Google Scholar
• Nesse RE. Abnormal vaginal bleeding in perimenopausal women. Am Fam Phys 1989;40:185–92
   PubMed Web of Science ®Google Scholar
• Hallberg L, Högdahl A, Nillson L, Rybo G. Menstrual blood loss*/a population study. Acta Obstet Gynecol Scand 1966;45:330–51
   Google Scholar
• Rybo G. Population studies of menorrhagia. Res Clin Forums 1983;5:77–81
   Google Scholar
• Henshaw SK. Unintended pregnancy in the United States. Fam Plann Perspect 1998;30:24–9
   PubMedGoogle Scholar
• Whitehead MI. General principles of administration of hormone replacement therapy: indications and contraindications, routes of administration, treatment schedules. In: Fraser IS, Jansen RPS, Lobo RA, Whitehead MI, eds. Estrogen and progestogens in clinical practice. London: Churchill Livingstone; 1998:667–86
   Google Scholar
• Furchgott RF, Zawadski JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acethylcholine. Nature 1980;288:373–6
   PubMed Web of Science ®Google Scholar
• , Heart and Estrogen/progestin Replacement Study (HERS) Research GroupHulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. J Am Med Assoc 1998;280:605–13
   Google Scholar
• Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions Trial. JAMA 1995;273:199–208
   PubMed Web of Science ®Google Scholar
• Prometrium. Available at: www.drug.com/pro/prometrium.html [last accessed November 2012]
   Google Scholar
• Horwitz KB, Sartorius CA. Progestins in hormone replacement therapies reactivate cancer stem cells in women with preexisting breast cancers: a hypothesis. J Clin Endocrinol Metab 2008;93:3295–8
   PubMed Web of Science ®Google Scholar
• Shao H, Breitner JC, Whitmer RA, et al.; For the Cache County Investigators. Hormone therapy and Alzheimer disease dementia: new findings from the Cache County Study. Neurology 2012;79:1846–52
   PubMed Web of Science ®Google Scholar
• Shumaker SA, Legault C, Kuller L, et al.; Women's Health Initiative Memory Study. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004;291:2947–58
   PubMed Web of Science ®Google Scholar
• Maki PM, Dennerstein L, Clark M, et al. Perimenopausal use of hormone therapy is associated with enhanced memory and hippocampal function later in life. Brain Research 2011;1379:232–43
   PubMed Web of Science ®Google Scholar
• Hammond CB. Women’s concerns with hormone replacement therapy – compliance issues. Fertil Steril 1994;62S2:157S–60S
   Google Scholar
• Hill DA, Weiss NS, La Croix AZ. Adherance to postmenopausal hormone therapy during the year after the initial prescription: a population based study. Am J Obstet Gynecol 2000;182:270–6
   PubMed Web of Science ®Google Scholar
• Castelo-Branco C, Figueras F, Sanjuan A, et al. Long-term compliance with estrogen replacement therapy in surgical postmenopausal women: benefits to bone and analysis of factors associated with discontinuation. J North Am Menopause Soc 1999;6:307–11
   PubMed Web of Science ®Google Scholar
• Ettinger B, Pressman A, Silver P. Effect of age on reasons for initiation and discontinuation of hormone replacement therapy. J North Am Menopause Soc 1999;6:282–9
   PubMed Web of Science ®Google Scholar